Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2017 Filed Mar 4, 2017 01:23 UTC |
Jensen ChrystalChief Legal Officer
|
GrantRestricted Stock Unit · Derivative | 22,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-018083 · doc4.xml · derivative · entry 2 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 01:23 UTC |
Jensen ChrystalChief Legal Officer
|
GrantOption (Right to Buy) · Derivative | 100,000 | Not disclosed Strike: $4.33 | Not disclosed |
DisclosureSEC source: 0001209191-17-018083 · doc4.xml · derivative · entry 1 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-02-28 F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option shall vest six (6) months after the transaction date and one forty-eighth (1/48th) of the shares subject to the Option shall vest on each monthly anniversary of the transaction date thereafter. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 01:23 UTC |
Greenman William MarinerDirector · President and CEO
|
GrantRestricted Stock Unit · Derivative | 84,375 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-018082 · doc4.xml · derivative · entry 2 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,375 Underlying: Common Stock · 84,375 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 01:23 UTC |
Greenman William MarinerDirector · President and CEO
|
GrantOption (Right to Buy) · Derivative | 400,000 | Not disclosed Strike: $4.33 | Not disclosed |
DisclosureSEC source: 0001209191-17-018082 · doc4.xml · derivative · entry 1 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2027-02-28 F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option shall vest six (6) months after the transaction date and one forty-eighth (1/48th) of the shares subject to the Option shall vest on each monthly anniversary of the transaction date thereafter. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 01:22 UTC |
Green Kevin DennisChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 22,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-018080 · doc4.xml · derivative · entry 2 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 01:22 UTC |
Green Kevin DennisChief Financial Officer
|
GrantOption (Right to Buy) · Derivative | 100,000 | Not disclosed Strike: $4.33 | Not disclosed |
DisclosureSEC source: 0001209191-17-018080 · doc4.xml · derivative · entry 1 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-02-28 F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option shall vest six (6) months after the transaction date and one forty-eighth (1/48th) of the shares subject to the Option shall vest on each monthly anniversary of the transaction date thereafter. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 01:21 UTC |
CORASH LAURENCE MDirector · Chief Scientific Officer
|
GrantRestricted Stock Unit · Derivative | 22,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-018079 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 01:21 UTC |
CORASH LAURENCE MDirector · Chief Scientific Officer
|
GrantOption (Right to Buy) · Derivative | 100,000 | Not disclosed Strike: $4.33 | Not disclosed |
DisclosureSEC source: 0001209191-17-018079 · doc4.xml · derivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-02-28 F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option shall vest six (6) months after the transaction date and one forty-eighth (1/48th) of the shares subject to the Option shall vest on each monthly anniversary of the transaction date thereafter. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 01:20 UTC |
Benjamin Richard JChief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 22,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-018078 · doc4.xml · derivative · entry 2 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 01:20 UTC |
Benjamin Richard JChief Medical Officer
|
GrantOption (Right to Buy) · Derivative | 100,000 | Not disclosed Strike: $4.33 | Not disclosed |
DisclosureSEC source: 0001209191-17-018078 · doc4.xml · derivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-02-28 F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option shall vest six (6) months after the transaction date and one forty-eighth (1/48th) of the shares subject to the Option shall vest on each monthly anniversary of the transaction date thereafter. Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 10:04 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionOption (Right to Buy) · Derivative | 55,000 | Not disclosed Strike: $5.55 | Not disclosed |
DisclosureSEC source: 0001209191-16-143455 · doc4.xml · derivative · entry 2 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 55,000 shares Expires 2016-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not applicable. F2 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 10:04 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionCommon Stock | 55,000 | $5.55 | $305,250.00 |
DisclosureSEC source: 0001209191-16-143455 · doc4.xml · nonDerivative · entry 1 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares purchased pursuant to a qualified Employee Stock Purchase Plan on 2/27/2015 of 3,352 shares, on 8/31/2015 of 3,245 shares, on 2/29/2016 of 5,486 shares and on 8/31/2016 of 105 shares. Also includes 21,800 shares purchased on 11/10/2014 and reported on a Form 4 filed on 11/12/2014. Read SEC document |
| September 22, 2016 Filed Sep 23, 2016 22:13 UTC |
CORASH LAURENCE MDirector · Chief Scientific Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 21,000 | Not disclosed Strike: $5.55 | Not disclosed |
DisclosureSEC source: 0001209191-16-142684 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,000 shares Expires 2016-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| September 22, 2016 Filed Sep 23, 2016 22:13 UTC |
CORASH LAURENCE MDirector · Chief Scientific Officer
|
Exercise / conversionCommon Stock | 21,000 | $5.55 | $116,550.00 |
DisclosureSEC source: 0001209191-16-142684 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,319,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2016 Filed Sep 17, 2016 00:28 UTC |
CORASH LAURENCE MDirector · Chief Scientific Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 9,000 | Not disclosed Strike: $5.55 | Not disclosed |
DisclosureSEC source: 0001209191-16-141891 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 9,000 shares Expires 2016-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| September 15, 2016 Filed Sep 17, 2016 00:28 UTC |
CORASH LAURENCE MDirector · Chief Scientific Officer
|
Exercise / conversionCommon Stock | 9,000 | $5.55 | $49,950.00 |
DisclosureSEC source: 0001209191-16-141891 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,298,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2014 Filed Aug 16, 2018 22:06 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 35,416 | $7.20 | $255,016.45 |
DisclosureSEC source: 0001209191-18-047165 · doc4.xml · nonDerivative · entry 2 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.